Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited - PE Ratioverified

600332.SS

Price:

$21.51

Market Cap:

$34.97B

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GBPHCL), along with its various subsidiaries, operates as a comprehensive pharmaceutical enterprise. It is actively engaged in the research, development, production, and distribution of a wide array of products, including traditional Chinese patent medicines, Western pharmaceuticals, chemical raw materials, natural and biological medications, and chemical raw material intermediates. Its operations span both the People's Republic of China and international markets. The company structures its extensive operations into four primary segments: Great Southern TCM, Great Commerce, Great Health, and a miscellaneous 'Others' category. Beyo...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2001-02-06

Stock Exchange

SHH

Ticker

600332.SS

The PE Ratio as of August 2026 (TTM) for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (600332.SS) is 11.83

According to Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited’s latest financial reports and current stock price. The company's current PE Ratio is 11.83. This represents a change of 3.32% compared to the average of 0.35 of the last 4 quarters.

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (600332.SS) Historical PE Ratio (quarterly & annually)

How has 600332.SS PE Ratio performed in the past?

The mean historical PE Ratio of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited over the last ten years is 16.73. The current 11.83 PE Ratio has changed 6.97% with respect to the historical average. Over the past ten years (40 quarters), 600332.SS's PE Ratio was at its highest in in the December 2018 quarter at 8.57K. The PE Ratio was at its lowest in in the December 2024 quarter at -35.70.

Quarterly (TTM)
Annual

Average

16.73

Median

16.25

Minimum

11.57

Maximum

25.31

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (600332.SS) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 41.12%

Maximum Annual PE Ratio = 25.31

Minimum Annual Increase = -36.12%

Minimum Annual PE Ratio = 11.57

Quarterly (TTM)
Annual
YearPE RatioChange
202514.07-13.88%
202416.3341.12%
202311.57-5.20%
202212.21-18.25%
202114.93-8.61%
202016.34-10.06%
201918.1712.39%
201816.17-36.12%
201725.3113.98%
201622.20-25.94%

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (600332.SS) Average PE Ratio

How has 600332.SS PE Ratio performed in the past?

The current PE Ratio of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (600332.SS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

13.99

5-year avg

13.82

10-year avg

16.73

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (600332.SS) PE Ratio vs. Peers

How is 600332.SS’s PE Ratio compared to its peers?

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited’s PE Ratio is less than China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (12.70), less than Changchun High-Tech Industries (Group) Inc. (406.90), less than Livzon Pharmaceutical Group Inc. (13.87), less than Beijing Tongrentang Co., Ltd (31.90), less than Humanwell Healthcare (Group) Co.,Ltd. (15.44), less than Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (12.99), less than Dong-E-E-Jiao Co.,Ltd. (19.09), less than Chengdu Kanghong Pharmaceutical Group Co., Ltd (19.87), less than Hubei Jumpcan Pharmaceutical Co., Ltd. (13.16), less than Gan & Lee Pharmaceuticals. (44.79),

Build a custom stock screener for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (600332.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (600332.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited's PE Ratio?

How is the PE Ratio calculated for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (600332.SS)?

What is the highest PE Ratio for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (600332.SS)?

What is the 3-year average PE Ratio for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (600332.SS)?

What is the 5-year average PE Ratio for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (600332.SS)?

How does the current PE Ratio for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (600332.SS) compare to its historical average?